Tokyo Tape
Sign in
← Takara Holdings

Quarterly report · Q2

2531.TEDINET S100PIJL
Period2022-04-01 → 2022-09-30
Filed2022-11-11
StandardJapan GAAP
ConsolidatedYes
Data checks14 of 14 passed
Key figures · 46
MetricValuePeriodScopeSource row
Revenue¥164.3bn2022-04-01 → 2022-09-30Cons.Net sales
Revenue¥300.9bn2021-04-01 → 2022-03-31Cons.Net sales (5-year summary)
Revenue¥141.2bn2021-04-01 → 2021-09-30Cons.Net sales
Operating income¥19.6bn2022-04-01 → 2022-09-30Cons.Operating income
Operating income¥21.6bn2021-04-01 → 2021-09-30Cons.Operating income
Ordinary income¥20.0bn2022-04-01 → 2022-09-30Cons.Ordinary income
Ordinary income¥43.2bn2021-04-01 → 2022-03-31Cons.Ordinary income loss (5-year summary)
Ordinary income¥21.9bn2021-04-01 → 2021-09-30Cons.Ordinary income
Profit before tax¥20.8bn2022-04-01 → 2022-09-30Cons.Income before income taxes
Profit before tax¥20.4bn2021-04-01 → 2021-09-30Cons.Income before income taxes
Net income (owners)¥10.9bn2022-04-01 → 2022-09-30Cons.Profit loss attributable to owners of parent
Net income (owners)¥20.8bn2021-04-01 → 2022-03-31Cons.Profit loss attributable to owners of parent (5-year summary)
Net income (owners)¥10.1bn2021-04-01 → 2021-09-30Cons.Profit loss attributable to owners of parent
Net income¥14.8bn2022-04-01 → 2022-09-30Cons.Profit loss
Net income¥14.4bn2021-04-01 → 2021-09-30Cons.Profit loss
Total assets¥366.3bnat 2022-09-30Cons.Assets
Total assets¥362.4bnat 2022-03-31Cons.Assets
Total assets¥328.1bnat 2021-09-30Cons.Total assets (5-year summary)
Total liabilities¥122.0bnat 2022-09-30Cons.Liabilities
Total liabilities¥137.9bnat 2022-03-31Cons.Liabilities
Net assets / equity¥244.3bnat 2022-09-30Cons.Net assets
Net assets / equity¥224.6bnat 2022-03-31Cons.Net assets
Net assets / equity¥205.8bnat 2021-09-30Cons.Net assets (5-year summary)
Cash and deposits¥67.1bnat 2022-09-30Cons.Cash and deposits
Cash and deposits¥80.4bnat 2022-03-31Cons.Cash and deposits
Cash & equivalents¥56.0bnat 2022-09-30Cons.Cash and cash equivalents
Cash & equivalents¥75.7bnat 2022-03-31Cons.Cash and cash equivalents
Cash & equivalents¥58.8bnat 2021-09-30Cons.Cash and cash equivalents
Cash & equivalents¥62.9bnat 2021-03-31dCons.Cash and cash equivalents
Operating cash flow¥7.2bn2022-04-01 → 2022-09-30Cons.Net cash provided by used in operating activities
Operating cash flow¥16.4bn2021-04-01 → 2022-03-31Cons.Net cash provided by used in operating activities (5-year summary)
Operating cash flow¥11.8bn2021-04-01 → 2021-09-30Cons.Net cash provided by used in operating activities
Investing cash flow−¥9.6bn2022-04-01 → 2022-09-30Cons.Net cash provided by used in investment activities
Investing cash flow−¥10.4bn2021-04-01 → 2022-03-31Cons.Net cash provided by used in investing activities (5-year summary)
Investing cash flow−¥12.1bn2021-04-01 → 2021-09-30Cons.Net cash provided by used in investment activities
Financing cash flow−¥21.6bn2022-04-01 → 2022-09-30Cons.Net cash provided by used in financing activities
Financing cash flow¥4.1bn2021-04-01 → 2022-03-31Cons.Net cash provided by used in financing activities (5-year summary)
Financing cash flow−¥5.6bn2021-04-01 → 2021-09-30Cons.Net cash provided by used in financing activities
EPS (basic)¥552022-04-01 → 2022-09-30Cons.Basic earnings loss per share (5-year summary)
EPS (basic)¥28.482022-07-01 → 2022-09-30dCons.Basic earnings loss per share (5-year summary)
EPS (basic)¥105.052021-04-01 → 2022-03-31Cons.Basic earnings loss per share (5-year summary)
EPS (basic)¥50.842021-04-01 → 2021-09-30Cons.Basic earnings loss per share (5-year summary)
EPS (basic)¥23.782021-07-01 → 2021-09-30dCons.Basic earnings loss per share (5-year summary)
Equity ratio53.3%at 2022-09-30Cons.Equity to asset ratio (5-year summary)
Equity ratio49.8%at 2022-03-31Cons.Equity to asset ratio (5-year summary)
Equity ratio50.7%at 2021-09-30Cons.Equity to asset ratio (5-year summary)

Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.

Segments · 54
SegmentItemPeriodValue
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentsrevenue2022-04-01 → 2022-09-30¥15.6bn
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentsrevenue external2022-04-01 → 2022-09-30¥6.7bn
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentsrevenue intersegment2022-04-01 → 2022-09-30¥8.8bn
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentssegment profit2022-04-01 → 2022-09-30¥1.2bn
Reconciling Itemsreconcilingrevenue2022-04-01 → 2022-09-30−¥9.4bn
Reconciling Itemsreconcilingrevenue intersegment2022-04-01 → 2022-09-30−¥9.4bn
Reconciling Itemsreconcilingsegment profit2022-04-01 → 2022-09-30−¥216m
jpcrp040300-q2r_E00396-000Takara Bio Groupreportable segmentrevenue2022-04-01 → 2022-09-30¥63.7bn
jpcrp040300-q2r_E00396-000Takara Bio Groupreportable segmentrevenue external2022-04-01 → 2022-09-30¥63.6bn
jpcrp040300-q2r_E00396-000Takara Bio Groupreportable segmentrevenue intersegment2022-04-01 → 2022-09-30¥121m
jpcrp040300-q2r_E00396-000Takara Bio Groupreportable segmentsegment profit2022-04-01 → 2022-09-30¥5.7bn
jpcrp040300-q2r_E00396-000Takara Healthcarereportable segmentrevenue2022-04-01 → 2022-09-30¥32.6bn
jpcrp040300-q2r_E00396-000Takara Healthcarereportable segmentrevenue external2022-04-01 → 2022-09-30¥32.6bn
jpcrp040300-q2r_E00396-000Takara Healthcarereportable segmentrevenue intersegment2022-04-01 → 2022-09-30¥2m
jpcrp040300-q2r_E00396-000Takara Healthcarereportable segmentsegment profit2022-04-01 → 2022-09-30¥10.9bn
jpcrp040300-q2r_E00396-000Takara Shuzo Groupreportable segmentrevenue2022-04-01 → 2022-09-30¥61.8bn
jpcrp040300-q2r_E00396-000Takara Shuzo Groupreportable segmentrevenue external2022-04-01 → 2022-09-30¥61.3bn
jpcrp040300-q2r_E00396-000Takara Shuzo Groupreportable segmentrevenue intersegment2022-04-01 → 2022-09-30¥483m
jpcrp040300-q2r_E00396-000Takara Shuzo Groupreportable segmentsegment profit2022-04-01 → 2022-09-30¥2.1bn
—segment totalrevenue2022-04-01 → 2022-09-30¥158.1bn
—segment totalrevenue external2022-04-01 → 2022-09-30¥157.5bn
—segment totalrevenue intersegment2022-04-01 → 2022-09-30¥608m
—segment totalsegment profit2022-04-01 → 2022-09-30¥18.6bn
Total Of Reportable Segments And Otherssegment totalrevenue2022-04-01 → 2022-09-30¥173.7bn
Total Of Reportable Segments And Otherssegment totalrevenue external2022-04-01 → 2022-09-30¥164.3bn
Total Of Reportable Segments And Otherssegment totalrevenue intersegment2022-04-01 → 2022-09-30¥9.4bn
Total Of Reportable Segments And Otherssegment totalsegment profit2022-04-01 → 2022-09-30¥19.8bn
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentsrevenue2021-04-01 → 2021-09-30¥14.6bn
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentsrevenue external2021-04-01 → 2021-09-30¥5.9bn
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentsrevenue intersegment2021-04-01 → 2021-09-30¥8.7bn
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentssegment profit2021-04-01 → 2021-09-30¥1.0bn
Reconciling Itemsreconcilingrevenue2021-04-01 → 2021-09-30−¥9.3bn
Reconciling Itemsreconcilingrevenue intersegment2021-04-01 → 2021-09-30−¥9.3bn
Reconciling Itemsreconcilingsegment profit2021-04-01 → 2021-09-30−¥93m
jpcrp040300-q2r_E00396-000Takara Bio Groupreportable segmentrevenue2021-04-01 → 2021-09-30¥46.7bn
jpcrp040300-q2r_E00396-000Takara Bio Groupreportable segmentrevenue external2021-04-01 → 2021-09-30¥46.6bn
jpcrp040300-q2r_E00396-000Takara Bio Groupreportable segmentrevenue intersegment2021-04-01 → 2021-09-30¥170m
jpcrp040300-q2r_E00396-000Takara Bio Groupreportable segmentsegment profit2021-04-01 → 2021-09-30¥4.3bn
jpcrp040300-q2r_E00396-000Takara Healthcarereportable segmentrevenue2021-04-01 → 2021-09-30¥31.6bn
jpcrp040300-q2r_E00396-000Takara Healthcarereportable segmentrevenue external2021-04-01 → 2021-09-30¥31.6bn
jpcrp040300-q2r_E00396-000Takara Healthcarereportable segmentrevenue intersegment2021-04-01 → 2021-09-30¥0
jpcrp040300-q2r_E00396-000Takara Healthcarereportable segmentsegment profit2021-04-01 → 2021-09-30¥14.1bn
jpcrp040300-q2r_E00396-000Takara Shuzo Groupreportable segmentrevenue2021-04-01 → 2021-09-30¥57.6bn
jpcrp040300-q2r_E00396-000Takara Shuzo Groupreportable segmentrevenue external2021-04-01 → 2021-09-30¥57.2bn
jpcrp040300-q2r_E00396-000Takara Shuzo Groupreportable segmentrevenue intersegment2021-04-01 → 2021-09-30¥431m
jpcrp040300-q2r_E00396-000Takara Shuzo Groupreportable segmentsegment profit2021-04-01 → 2021-09-30¥2.3bn
—segment totalrevenue2021-04-01 → 2021-09-30¥135.9bn
—segment totalrevenue external2021-04-01 → 2021-09-30¥135.3bn
—segment totalrevenue intersegment2021-04-01 → 2021-09-30¥601m
—segment totalsegment profit2021-04-01 → 2021-09-30¥20.7bn
Total Of Reportable Segments And Otherssegment totalrevenue2021-04-01 → 2021-09-30¥150.5bn
Total Of Reportable Segments And Otherssegment totalrevenue external2021-04-01 → 2021-09-30¥141.2bn
Total Of Reportable Segments And Otherssegment totalrevenue intersegment2021-04-01 → 2021-09-30¥9.3bn
Total Of Reportable Segments And Otherssegment totalsegment profit2021-04-01 → 2021-09-30¥21.7bn

Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.

All source rows · 524
ItemContextValueUnit
Long term loans payableCurrentQuarterInstant15171000000JPY
Net defined benefit liabilityPrior1YearInstant8944000000JPY
Net defined benefit liabilityCurrentQuarterInstant8879000000JPY
Other nclPrior1YearInstant14537000000JPY
Other nclCurrentQuarterInstant15012000000JPY
Noncurrent liabilitiesPrior1YearInstant58730000000JPY
Noncurrent liabilitiesCurrentQuarterInstant59063000000JPY
LiabilitiesPrior1YearInstant137882000000JPY
LiabilitiesCurrentQuarterInstant121956000000JPY
Capital stockPrior1YearInstant13226000000JPY
Capital stockCurrentQuarterInstant13226000000JPY
Capital surplusPrior1YearInstant2499000000JPY
Capital surplusCurrentQuarterInstant1918000000JPY
Retained earningsPrior1YearInstant149933000000JPY
Retained earningsCurrentQuarterInstant153492000000JPY
Treasury stockPrior1YearInstant-1682000000JPY
Treasury stockCurrentQuarterInstant-1682000000JPY
Shareholders equityPrior1YearInstant163976000000JPY
Shareholders equityCurrentQuarterInstant166954000000JPY
Valuation difference on available for sale securitiesPrior1YearInstant12216000000JPY
Valuation difference on available for sale securitiesCurrentQuarterInstant11103000000JPY
Deferred gains or losses on hedgesPrior1YearInstant412000000JPY
Deferred gains or losses on hedgesCurrentQuarterInstant784000000JPY
Foreign currency translation adjustmentPrior1YearInstant4330000000JPY
Foreign currency translation adjustmentCurrentQuarterInstant16959000000JPY
Remeasurements of defined benefit plansPrior1YearInstant-515000000JPY
Remeasurements of defined benefit plansCurrentQuarterInstant-441000000JPY
Valuation and translation adjustmentsPrior1YearInstant16443000000JPY
Valuation and translation adjustmentsCurrentQuarterInstant28405000000JPY
Non controlling interestsPrior1YearInstant44135000000JPY
Non controlling interestsCurrentQuarterInstant48957000000JPY
Net assetsPrior1YearInstant224555000000JPY
Net assetsCurrentQuarterInstant244317000000JPY
Liabilities and net assetsPrior1YearInstant362438000000JPY
Liabilities and net assetsCurrentQuarterInstant366273000000JPY
Net salesPrior1YTDDuration141213000000JPY
Net salesCurrentYTDDuration164279000000JPY
Cost of salesPrior1YTDDuration86872000000JPY
Cost of salesCurrentYTDDuration106400000000JPY
Gross profitPrior1YTDDuration54340000000JPY
Gross profitCurrentYTDDuration57879000000JPY
Selling general and administrative expensesPrior1YTDDuration32724000000JPY
Selling general and administrative expensesCurrentYTDDuration38264000000JPY
Operating incomePrior1YTDDuration21616000000JPY
Operating incomeCurrentYTDDuration19614000000JPY
Dividends income noiPrior1YTDDuration311000000JPY
Dividends income noiCurrentYTDDuration445000000JPY
Other noiPrior1YTDDuration357000000JPY
Other noiCurrentYTDDuration452000000JPY
Non operating incomePrior1YTDDuration669000000JPY

Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.

Data checks · 14 of 14 passed
balance sheet identityconsolidated 2022-03-31pass rounding
balance sheet identityconsolidated 2022-09-30pass
dei present pass
period resolution pass
statement vs summary · net assetsconsolidated 2022-03-31pass
statement vs summary · net assetsconsolidated 2022-09-30pass
statement vs summary · net income attributable to parentconsolidated 2021-04-01/2021-09-30pass
statement vs summary · net income attributable to parentconsolidated 2022-04-01/2022-09-30pass
statement vs summary · operating cash flowconsolidated 2021-04-01/2021-09-30pass
statement vs summary · operating cash flowconsolidated 2022-04-01/2022-09-30pass
statement vs summary · revenueconsolidated 2021-04-01/2021-09-30pass
statement vs summary · revenueconsolidated 2022-04-01/2022-09-30pass
statement vs summary · total assetsconsolidated 2022-03-31pass
statement vs summary · total assetsconsolidated 2022-09-30pass